Concentration gradients of monoamines, their precursors and metabolites in serial lumbar cerebrospinal fluid of neurologically healthy patients determined with a novel LC-MS/MS technique.
Biogenic amines
Cerebrospinal fluid (CSF)
Concentration gradients
LC–MS/MS
Journal
Fluids and barriers of the CNS
ISSN: 2045-8118
Titre abrégé: Fluids Barriers CNS
Pays: England
ID NLM: 101553157
Informations de publication
Date de publication:
13 Feb 2023
13 Feb 2023
Historique:
received:
28
10
2022
accepted:
05
02
2023
entrez:
14
2
2023
pubmed:
15
2
2023
medline:
16
2
2023
Statut:
epublish
Résumé
Potential biomarkers for neuropsychiatric disorders are cerebrospinal fluid (CSF) monoamines and their corresponding precursors and metabolites. During CSF sampling, CSF flows towards the lumbar sampling site from more cranial regions. To compare the results of studies in which different CSF volumes were acquired, it is important to know if ventricular-lumbar concentration gradients exist. This has only been addressed for a few biogenic amines, and almost exclusively in neurologically unwell patients due to the burden of a lumbar puncture (necessary to obtain CSF). The aim of our study was to determine if concentration gradients exist for routinely measured CSF constituents and biogenic amines in neurologically healthy patients. We applied a novel ultrasensitive liquid chromatography mass spectrometry (LC-MS/MS) method for the simultaneous quantification of multiple monoamines, precursors and metabolites in CSF and plasma. CSF and blood samples were collected from twenty neurologically healthy patients undergoing spinal anaesthesia. Ten mL of lumbar CSF was collected in five consecutive two mL fractions. We determined leucocyte and erythrocyte counts, glucose, albumin and protein concentrations and quantified monoamines, precursors and metabolites on each of the fractions using LC-MS/MS. In twenty patients (60% male; median age: 46 years), dopamine, DOPAC, 3-MT, HVA, noradrenaline, normetanephrine and 5-HIAA concentrations increased from the first to the last CSF fraction (all p < 0.001). CSF adrenaline concentrations were below the detection limit, whereas serotonin measurements were regarded as unreliable. Albumin and total protein levels decreased significantly across CSF fractions. A ventricular-lumbar CSF concentration gradient existed for most of the investigated analytes. This is a novel finding for dopamine, noradrenaline, 3-MT and normetanephrine. These results contribute to the understanding of the neurobiology and underline the importance of standardized procedures for CSF handling to allow comparisons between studies.
Sections du résumé
BACKGROUND
BACKGROUND
Potential biomarkers for neuropsychiatric disorders are cerebrospinal fluid (CSF) monoamines and their corresponding precursors and metabolites. During CSF sampling, CSF flows towards the lumbar sampling site from more cranial regions. To compare the results of studies in which different CSF volumes were acquired, it is important to know if ventricular-lumbar concentration gradients exist. This has only been addressed for a few biogenic amines, and almost exclusively in neurologically unwell patients due to the burden of a lumbar puncture (necessary to obtain CSF). The aim of our study was to determine if concentration gradients exist for routinely measured CSF constituents and biogenic amines in neurologically healthy patients. We applied a novel ultrasensitive liquid chromatography mass spectrometry (LC-MS/MS) method for the simultaneous quantification of multiple monoamines, precursors and metabolites in CSF and plasma.
METHODS
METHODS
CSF and blood samples were collected from twenty neurologically healthy patients undergoing spinal anaesthesia. Ten mL of lumbar CSF was collected in five consecutive two mL fractions. We determined leucocyte and erythrocyte counts, glucose, albumin and protein concentrations and quantified monoamines, precursors and metabolites on each of the fractions using LC-MS/MS.
RESULTS
RESULTS
In twenty patients (60% male; median age: 46 years), dopamine, DOPAC, 3-MT, HVA, noradrenaline, normetanephrine and 5-HIAA concentrations increased from the first to the last CSF fraction (all p < 0.001). CSF adrenaline concentrations were below the detection limit, whereas serotonin measurements were regarded as unreliable. Albumin and total protein levels decreased significantly across CSF fractions.
CONCLUSIONS
CONCLUSIONS
A ventricular-lumbar CSF concentration gradient existed for most of the investigated analytes. This is a novel finding for dopamine, noradrenaline, 3-MT and normetanephrine. These results contribute to the understanding of the neurobiology and underline the importance of standardized procedures for CSF handling to allow comparisons between studies.
Identifiants
pubmed: 36782208
doi: 10.1186/s12987-023-00413-8
pii: 10.1186/s12987-023-00413-8
pmc: PMC9923930
doi:
Substances chimiques
Dopamine
VTD58H1Z2X
Normetanephrine
0J45DE6B88
Homovanillic Acid
X77S6GMS36
Biogenic Amines
0
Norepinephrine
X4W3ENH1CV
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
13Informations de copyright
© 2023. The Author(s).
Références
Clin Chem. 2019 Nov;65(11):1388-1396
pubmed: 31551315
Hypertension. 1979 May-Jun;1(3):255-60
pubmed: 399237
Mol Psychiatry. 2021 Mar;26(3):897-906
pubmed: 31138892
J Inherit Metab Dis. 2018 Nov;41(6):1147-1158
pubmed: 29974349
Anal Chem. 2020 Jul 7;92(13):9072-9078
pubmed: 32484659
Front Hum Neurosci. 2022 Jan 21;15:737217
pubmed: 35126070
Am Fam Physician. 2003 Sep 15;68(6):1103-8
pubmed: 14524396
J Neurosci Methods. 2010 Aug 30;191(2):244-8
pubmed: 20599557
Behav Res Methods. 2007 May;39(2):175-91
pubmed: 17695343
Acta Neurol Scand. 2017 Jan;135(1):34-56
pubmed: 26991855
Cureus. 2020 Jul 21;12(7):e9315
pubmed: 32850195
J Neurol Sci. 2020 Aug 15;415:116886
pubmed: 32428759
J Neural Transm Gen Sect. 1991;84(1-2):103-17
pubmed: 1675857
Eur Neuropsychopharmacol. 2018 Jul;28(7):783-794
pubmed: 29802040
J Affect Disord. 2018 Nov;240:6-16
pubmed: 30041075
J Psychiatr Res. 2021 Apr;136:224-235
pubmed: 33618064
Handb Clin Neurol. 2017;146:21-32
pubmed: 29110772
J Neurol Sci. 1994 Apr;122(2):189-203
pubmed: 8021703
J Psychiatr Res. 2018 Oct;105:137-146
pubmed: 30219563
Eur Neuropsychopharmacol. 1993 Mar;3(1):55-61
pubmed: 7682460
Nat Rev Neurol. 2015 Oct;11(10):567-84
pubmed: 26392380
Neurology. 2009 Dec 1;73(22):1914-22
pubmed: 19949037
Acta Neurol Scand. 1975 Aug;52(2):137-44
pubmed: 1155031
Clin Chim Acta. 1984 Nov 30;143(3):193-201
pubmed: 6499218
J Psychiatr Res. 1996 May-Jun;30(3):201-8
pubmed: 8884658
Pharmacol Rev. 1966 Dec;18(4):1201-38
pubmed: 4959625
Restor Neurol Neurosci. 2003;21(3-4):79-96
pubmed: 14530572
Adv Biochem Psychopharmacol. 1984;39:57-68
pubmed: 6464833
J Neurochem. 1977 Mar;28(3):677-9
pubmed: 404398
Neuropediatrics. 2019 Feb;50(1):2-14
pubmed: 30372766
Neurohospitalist. 2022 Jan;12(1):151-154
pubmed: 34950405
Neurology. 1982 Aug;32(8):893-4
pubmed: 7201587
Eur Neurol. 1993;33(2):126-8
pubmed: 8467818
Clin Chem Lab Med. 2004;42(7):833-41
pubmed: 15327020
J Psychiatr Res. 1995 Mar-Apr;29(2):133-40
pubmed: 7545235
Pharmacopsychiatry. 1995 Mar;28(2):45-50
pubmed: 7542785
J Neurol Neurosurg Psychiatry. 1994 Sep;57(9):1026-33
pubmed: 7522267
Ann Transl Med. 2021 Mar;9(6):455
pubmed: 33850852
J Alzheimers Dis. 2014;41(4):1057-62
pubmed: 24748118
J Neurol Neurosurg Psychiatry. 1975 Jul;38(7):666-8
pubmed: 1159438
PLoS One. 2014 Mar 05;9(3):e90429
pubmed: 24599184
Clin Chim Acta. 2001 Aug 20;310(2):173-86
pubmed: 11498083
Alzheimers Res Ther. 2019 Jul 19;11(1):63
pubmed: 31324260
J Psychiatr Res. 1994 Nov-Dec;28(6):511-7
pubmed: 7699610
Synapse. 2014 Oct;68(10):480-3
pubmed: 24988901
J Psychiatr Res. 1996 Mar-Apr;30(2):127-33
pubmed: 8816306
Lancet Neurol. 2011 Aug;10(8):721-33
pubmed: 21777827
J Clin Psychiatry. 2017 Sep/Oct;78(8):e947-e956
pubmed: 28749090
J Neurochem. 1990 Apr;54(4):1148-56
pubmed: 1968956
J Neural Transm Park Dis Dement Sect. 1993;5(1):5-15
pubmed: 7679905
Brain Behav Immun. 2017 Feb;60:1-12
pubmed: 26995317
J Chromatogr A. 2007 Mar 23;1145(1-2):241-5
pubmed: 17306280
J Neurol. 1978 May 18;218(2):77-96
pubmed: 78976